Learn valuable insights and strategies from industry experts.
This webinar provides a basic grounding of CAPA, its origins, use, and the connection to today’s FDA’s 21 CFR Part 820 Subpart J-Corrective and Preventive Action.
Your CAPA system should not be a dutiful exercise in regulatory compliance but rather an integral part of your company’s risk mitigation for future product or service development, marketing, and sales. CAPA provides a structured framework for compliant and increased quality processes and procedures in industries ranging from pharmaceuticals to medical devices to manufacturing and tech. Dr. Deming: “A system must be managed.” “Without an aim, there is no system. The aim must include plans for the future.” “To successfully respond to the myriad of changes that shake the world, transformation into a new style of management is required."
Willi Ramseier is currently the owner and director of QVRAM GmbH of Basel, Switzerland. As an expert in quality assurance, system validation, risk awareness, and management, Ramseier is a reputed trainer, mentor, and quality compliance officer.
Having worked at Hoffman-La Roche, he now consults across Europe as a process-validation expert at Synthes-DePuy-Johnston & Johnston Switzerland, a quality consultant and CSV advisor, and GxP Workshop Trainer for a CROs in Cologne and Dresden. He also is a teacher and lead auditor for ISO 9001:2015.
